NDAEPIDURALINJECTABLE, LIPOSOMAL
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
DEPODUR (morphine sulfate) by Pfizer is clinical pharmacology mechanism of action epidural administration of morphine sulfate results in analgesia without attendant loss of motor, sensory, or sympathetic function. Approved for chronic pain, pain, postoperative pain. First approved in 2004.
Drug data last refreshed 19h ago
Mechanism of Action
CLINICAL PHARMACOLOGY Mechanism of Action Epidural administration of morphine sulfate results in analgesia without attendant loss of motor, sensory, or sympathetic function. Morphine released from DepoDur is absorbed both neuraxially and systemically. Morphine, a pure opiate agonist, is relatively…
Worked on DEPODUR at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.